(1) Companies will receive a supportive bonus for R&D and industrialization when they gain permission to conduct clinical trials, production or registration certificates, or GMP (Good Manufacturing Practices) /GSP (Good Supply Practices) certificates for new medicine or medical apparatus and instrument.
(2) Customized GMP/GSP industrialization transformation facilities accelerate company's commercialization period of their research achievements, reducing risks and increasing market opportunities.